glp-1 kidney stones WCET 2025: The Impact of Receptor Agonists on Nephrolithiasis Amongst Patients with Obesity: Insights from a Real-World Data Analysis Kidney Stones and Wegovy: What

Gentle & Convenient Liquid Drops: Experience the ease of a comprehensive 27-in-1 liquid formula

2023 May 23;14:1181913

Here is what the evidence says about protecting your bones and muscle on GLP-1 therapy.

GLP-1 drugs may help boost heart attack recovery by lowering the risk of major complications, an animal study suggests.

Clinical trials (ten studies, 419 participants) using doses from 400 mg to 10 g over 21 days to 20 months show consistent reductions in fasting glucose, post-meal glucose, and HbA1c. In diabetic animal studies, gymnema increased proglucagon gene expression (a precursor for GLP-1) and insulin gene activity, suggesting it may help amplify endogenous GLP-1 production

Treatment options for these conditions are limited to invasive neurosurgery, and novel pharmacological approaches to manage ICP in pathology are sought